Cover Image

Improving animal health : reauthorization of FDA animal drug user fees : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining improving animal health, focusing on reauthorization of Food and Drug Administration animal drug user fees, February 13, 2018.

Bibliographic Details
Corporate Author:	United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions (Author)
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. Government Publishing Office, 2020.
Series:	S. hrg. ; 115-777
Subjects:	Veterinary drugs > Law and legislation > United States. Drug approval > United States. User charges > United States. United States. > Food and Drug Administration > Rules and practice. Legislative hearings.
Online Access:	https://purl.fdlp.gov/GPO/gpo133933

Similar Items

Animal drug user fee agreements : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, first session, on examining animal drug user fee agreements, focusing on advancing animal health for the public health, February 27, 2013.
Published: (2014)

Amending the Federal Food, Drug, and Cosmetic Act to reauthorize user fee programs relating to new animal drugs : report (to accompany H.R. 1407) (including cost estimate of the Congressional Budget Office).
Published: (2013)

FDA user fee agreements : improving medical product regulation and innovation for patients : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, first session on ... March 21, 2017.
Published: (2018)

Committee prints on administration legislative proposals on the Animal Drug User Fee Act Amendments of 2008 and the Animal Generic Drug User Fee Act of 2008 : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, June 5, 2008.
Published: (2008)

Animal Generic Drug User Fee Act of 2008 : report (to accompany H.R. 6433) (including cost estimate of the Congressional Budget Office).
Published: (2008)

FDA user fee agreements : strengthening FDA and the medical products industry for the benefit of patients : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, second session ... March 29, 2012.
Published: (2014)

FDA user fees : advancing public health : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, first session ... July 28, 2011.
Published: (2014)

User fees and refunds for premarket approval applications.
Published: (2009)

Animal Drug User Fee Amendments of 2008 : report (to accompany H.R. 6432) (including cost estimate of the Congressional Budget Office).
Published: (2008)

FDA user fee agreements: advancing medical product regulation and innovation for the benefit of patients, FDA center directors : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventeenth Congress, second session on examining Food and Drug Administration user fee agreements, focusing on advancing medical product regulation and innovation for the benefit of patients and Food and Drug Administration center directors, April 26, 2022.
Published: (2023)

Reauthorization of the Animal Drug User Fee Act (ADUFA).
Published: (2008)

Drug user fees : enhancing patient access and drug safety : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining enhancing patient access and drug safety relating to prescription drug user fees, including S. 484, March 14, 2007.
Published: (2008)

Guidance for industry and FDA staff : application user fees for combination products.
Published: (2005)

Guidance for industry : classifying resubmissions in response to action letters.
Published: (1998)

Food and Drug Administration : effect of user fees on drug approval times, withdrawals, and other agency activities.
Published: (2002)

Reauthorization of animal drug user fees : ADUFA and AGDUFA : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, March 14, 2018.
Published: (2018)

Committee prints on administration legislative proposals on the Animal Drug User Fee Act Amendments of 2008 and the Animal Generic Drug User Fee Act of 2008 : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, June 5, 2008.
Published: (2008)

Reauthorization of animal drug user fees : ADUFA and AGDUFA : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, April 9, 2013.
Published: (2013)

Reauthorization of Animal Drug User Fees : ADUFA and AGDUFA.
Published: (2013)

Reauthorization of Animal Drug User Fees : ADUFA and AGDUFA.
Published: (2018)

Animal drug user fee programs /
by: Dabrowska, Agata, et al.
Published: (2018)

Animal Drug User Fee Act of 2003 : report (to accompany H.R. 1260) (including cost estimate of the Congressional Budget Office).
Published: (2003)

Animal Drug User Fee Agreements : Advancing Animal Health for the Public.
Published: (2013)

Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session ... January 28, 2016.
Published: (2018)

Drug user fees : enhancing patient access and drug safety : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining enhancing patient access and drug safety relating to prescription drug user fees, including S. 484, March 14, 2007.
Published: (2008)

Guidebook for drug regulatory submissions /
by: Weinberg, Sandy, 1950-
Published: (2009)

Guidance for industry : submission of documentation in applications for parametric release of human and veterinary drug products terminally sterilized by moist heat processes.
Published: (2010)

Animal Drug and Animal Generic Drug User Fee Amendments of 2023 : report (to accompany H.R. 1418).
Published: (2023)

Guidance for industry : submission of documentation in applications for parametric release of human and veterinary drug products terminally sterilized by moist heat processes.
Published: (2008)

Rare diseases : expediting treatments for patients : hearing before the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining rare diseases, focusing on expediting treatments for patients, October 3, 2018.
Published: (2020)

CDER ... report to the nation : improving public health through human drugs /
Published: (1998)

Guidance for industry : referencing discontinued labeling for listed drugs in abbreviated new drug applications.
Published: (2000)

Reauthorization of the Animal Drug User Fee Act (ADUFA).
Published: (2008)

Reauthorization of the Animal Drug User Fee Act (ADUFA).
Published: (2008)

Reauthorization of the Animal Drug User Fee Act (ADUFA).
Published: (2008)

New drug approval : FDA needs to enhance its oversight of drugs approved on the basis of surrogate endpoints : report to the Ranking Member, Committee on Finance, U.S. Senate.
Published: (2009)

Guidance for industry : NDA's : impurities in drug substances.
Published: (2000)

Guidance for industry : Q3A impurities in new drug substances.
Published: (2008)

Guideline for submitting supporting documentation in drug applications for the manufacture of drug substances.
Published: (1987)